Arrowhead Drug Patent Portfolio

Arrowhead owns 1 orange book drug protected by 5 US patents Given below is the list of Arrowhead's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10597657 10 Sep, 2038
Active
US11214801 10 Sep, 2038
Active
US12365899 10 Sep, 2038
Active
US10294474 07 Mar, 2037
Active
US11174481 07 Mar, 2037
Active


Arrowhead's Family Patents


Family Patents



Arrowhead Drug List

Given below is the complete list of Arrowhead's drugs and the patents protecting them.


1. Redemplo

Redemplo is protected by 5 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10597657 10 Sep, 2038
(12 years from now)
Active
US11214801 10 Sep, 2038
(12 years from now)
Active
US12365899 10 Sep, 2038
(12 years from now)
Active
US10294474 07 Mar, 2037
(11 years from now)
Active
US11174481 07 Mar, 2037
(11 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Redemplo's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List